Background: MSCs have been proven to have immune modulation and anti-inflammation capabilities, but the mechanisms are still under investigation. Recently, oxylipins have been identified to be involved in the immuno-regulation function of MSCs. However, the impact of proinflammatory stimulation on the profiles of MSCs derived oxylipins has never been studied.
Methods: In the present research, we employed a newly developed UPLC-MS/MS method to identify and quantify the oxylipin profile of ADSCs under proinflammatory stimulation (TNF-α and IFN-𝛾).
Results: As a result, among the analyzed 71 oxylipins, we detected and quantified 49 oxylipins derived from six major n-6 and n-3 polyunsaturated fatty acids (PUFAs) including arachidonic (AA), linoleic (LA), alpha-linolenic (ALA), dihomo-𝛾-linolenic acid (DGLA), eicosapentaenoic (EPA), and docosahexaenoic (DHA) acids in all samples, while 4 oxylipins were detected only in a part of samples and 18 were not detected in all samples. Nine oxylipins were found to be significantly differentially produced in ADSCs after 24 hours of inflammatory stimulation, among which, several oxylipins were reported to be having anti-inflammation or proresolving functions and involved in lipid mediator switching.
Conclusions: The results reported here make a fundamental step towards a comprehensive characterization of MSCs derived oxylipins as potential modulators of inflammation and immunoreaction.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7
This is a list of supplementary files associated with this preprint. Click to download.
Supplementary table S1. Standard calibration curve of 71 target lipid metabolites. The peak area ratio between the analyte and its respective internal standard were used (“y”) and the concentrations (“x”) were calculated using the calibration curve equation. LLOQ(nMol/L) and ULOQ(nMol/L) represent lower and upper limit of quantification respectively.
Supplementary table S2. Quantification results of ADSCs derived oxylipins (nMol/sample). M1, M2 and M3 refer to ADSC samples without stimulation, while TI1, TI2 and TI3 refer to ADSC samples with stimulation of recombinant human IFN-γ (20 ng/ml) and TNF-α (20 ng/ml), n = 3 experimental replicates per group. N/A= below the limits of detection.
Supplementary table S3. A list of 41 metabolic pathway involved in differentially expressed oxylipins was analyzed using the HMDB database.
Loading...
Posted 19 Jan, 2021
Posted 19 Jan, 2021
Background: MSCs have been proven to have immune modulation and anti-inflammation capabilities, but the mechanisms are still under investigation. Recently, oxylipins have been identified to be involved in the immuno-regulation function of MSCs. However, the impact of proinflammatory stimulation on the profiles of MSCs derived oxylipins has never been studied.
Methods: In the present research, we employed a newly developed UPLC-MS/MS method to identify and quantify the oxylipin profile of ADSCs under proinflammatory stimulation (TNF-α and IFN-𝛾).
Results: As a result, among the analyzed 71 oxylipins, we detected and quantified 49 oxylipins derived from six major n-6 and n-3 polyunsaturated fatty acids (PUFAs) including arachidonic (AA), linoleic (LA), alpha-linolenic (ALA), dihomo-𝛾-linolenic acid (DGLA), eicosapentaenoic (EPA), and docosahexaenoic (DHA) acids in all samples, while 4 oxylipins were detected only in a part of samples and 18 were not detected in all samples. Nine oxylipins were found to be significantly differentially produced in ADSCs after 24 hours of inflammatory stimulation, among which, several oxylipins were reported to be having anti-inflammation or proresolving functions and involved in lipid mediator switching.
Conclusions: The results reported here make a fundamental step towards a comprehensive characterization of MSCs derived oxylipins as potential modulators of inflammation and immunoreaction.

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7
This is a list of supplementary files associated with this preprint. Click to download.
Supplementary table S1. Standard calibration curve of 71 target lipid metabolites. The peak area ratio between the analyte and its respective internal standard were used (“y”) and the concentrations (“x”) were calculated using the calibration curve equation. LLOQ(nMol/L) and ULOQ(nMol/L) represent lower and upper limit of quantification respectively.
Supplementary table S2. Quantification results of ADSCs derived oxylipins (nMol/sample). M1, M2 and M3 refer to ADSC samples without stimulation, while TI1, TI2 and TI3 refer to ADSC samples with stimulation of recombinant human IFN-γ (20 ng/ml) and TNF-α (20 ng/ml), n = 3 experimental replicates per group. N/A= below the limits of detection.
Supplementary table S3. A list of 41 metabolic pathway involved in differentially expressed oxylipins was analyzed using the HMDB database.
Loading...